These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 23069267
1. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction. McLean S, Bhattacharya M, Di Guglielmo GM. Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267 [Abstract] [Full Text] [Related]
2. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II. McLean S, Di Guglielmo GM. Biochem J; 2010 Jul 01; 429(1):137-45. PubMed ID: 20406198 [Abstract] [Full Text] [Related]
3. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC. Science; 2003 Sep 05; 301(5638):1394-7. PubMed ID: 12958365 [Abstract] [Full Text] [Related]
5. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II. Jacko AM, Nan L, Li S, Tan J, Zhao J, Kass DJ, Zhao Y. Cell Death Dis; 2016 Nov 17; 7(11):e2474. PubMed ID: 27853171 [Abstract] [Full Text] [Related]
6. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Qiu T, Wu X, Zhang F, Clemens TL, Wan M, Cao X. Nat Cell Biol; 2010 Mar 17; 12(3):224-34. PubMed ID: 20139972 [Abstract] [Full Text] [Related]
8. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR. Osman B, Doller A, Akool el-S, Holdener M, Hintermann E, Pfeilschifter J, Eberhardt W. Cell Signal; 2009 Dec 17; 21(12):1806-17. PubMed ID: 19666112 [Abstract] [Full Text] [Related]
11. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. Zúñiga JE, Groppe JC, Cui Y, Hinck CS, Contreras-Shannon V, Pakhomova ON, Yang J, Tang Y, Mendoza V, López-Casillas F, Sun L, Hinck AP. J Mol Biol; 2005 Dec 16; 354(5):1052-68. PubMed ID: 16289576 [Abstract] [Full Text] [Related]
12. Inhibition of type III TGF-β receptor aggravates lung fibrotic process. Ahn JY, Park S, Yun YS, Song JY. Biomed Pharmacother; 2010 Sep 16; 64(7):472-6. PubMed ID: 20359848 [Abstract] [Full Text] [Related]
14. Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit. Taniguchi A, Matsuzaki K, Nakano K, Kan M, McKeehan WL. In Vitro Cell Dev Biol Anim; 1998 Mar 16; 34(3):232-8. PubMed ID: 9557941 [Abstract] [Full Text] [Related]